CellCyte Genetics Corp. (CCYG.OB) and the Fred Hutchinson Cancer Research Center Sign a Test Collaboration Agreement
CellCyte Genetics Corp. is an emerging biotechnology company engaged in the discovery, development and commercialization of products that enhance the productivity of biotechnology research laboratories. The company's initial product line is comprised of the CCG-E45 culture chamber and related CCG-E45 incubator which have been in experimental use for the last several years. CellCyte announced today that it has signed a beta test collaboration agreement with the Fred Hutchinson Cancer Research Center in Seattle, Washington. The test is intended to evaluate the CCG-E45 culture chamber product as a supplement or replacement to their current methods of culturing specific cell lines. CellCyte's…